Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
2,049.80
1,727.90
2,642.22
2,747.58
2,630.54
2,493.48
2,894.93
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,049.80
1,727.90
2,642.22
2,747.58
2,630.54
2,493.48
2,894.93
Raw Material Cost
1,112.93
670.93
1,311.51
1,310.15
1,202.18
1,127.59
1,162.95
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
254.15
191.87
220.55
236.02
202.78
177.36
195.18
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.56
1.09
0.80
0.92
10.90
21.87
31.32
Selling and Distribution Expenses
598.11
560.36
725.84
873.95
950.48
1,005.86
1,113.40
Other Expenses
-20.50
-13.04
-15.82
-19.18
-18.92
-16.10
-13.79
Total Expenditure (Excl Depreciation)
1,761.78
1,293.85
2,100.46
2,229.27
2,177.11
2,171.69
2,364.99
Operating Profit (PBDIT) excl Other Income
288
434.09999999999997
541.8
518.3
453.40000000000003
321.8
529.9
Other Income
87.18
74.61
67.29
73.37
71.30
20.63
34.45
Operating Profit (PBDIT)
521.53
613.93
709.41
692.19
636.85
436.55
649.44
Interest
1.56
1.09
0.80
0.92
10.90
21.87
31.32
Exceptional Items
-249.60
-18.21
-240.99
-48.54
-69.86
-0.27
-0.19
Gross Profit (PBDT)
936.88
1,056.98
1,330.71
1,437.43
1,428.36
1,365.89
1,731.98
Depreciation
164.69
116.91
113.91
110.72
112.98
94.60
93.94
Profit Before Tax
105.68
477.71
353.71
532.00
443.12
319.81
523.99
Tax
-8.76
81.19
105.56
86.51
84.84
52.87
77.92
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
112.70
396.99
237.47
432.20
344.53
260.06
426.15
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
112.70
396.99
237.47
432.20
344.53
260.06
426.15
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.06
-0.46
10.68
13.29
13.75
15.20
15.98
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
112.64
396.53
248.15
445.49
358.28
275.26
442.12
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
7,437.65
7,487.15
7,319.75
7,185.63
6,829.07
4,107.90
3,911.73
Earnings per share (EPS)
0.22
0.79
0.47
0.86
0.79
0.61
1.0
Diluted Earnings per share
0.22
0.79
0.47
0.86
0.79
0.61
1.0
Operating Profit Margin (Excl OI)
13.16%
24.45%
19.99%
18.49%
17.2%
12.89%
18.0%
Gross Profit Margin
13.19%
34.41%
17.7%
23.39%
21.14%
16.62%
21.35%
PAT Margin
5.5%
22.98%
8.99%
15.73%
13.1%
10.43%
14.72%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 18.63% vs -34.60% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -71.60% vs 59.81% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -19.45% vs -16.01% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 45.45% vs 37.50% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of China Resources Boya Bio-pharmaceutical Group Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
2,049.80
0
2,049.80
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,049.80
0
2,049.80
Raw Material Cost
1,112.93
0
1,112.93
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
254.15
0
254.15
Power Cost
0
0
0.00
Manufacturing Expenses
1.56
0
1.56
Selling and Distribution Expenses
598.11
0
598.11
Other Expenses
-20.50
0.00
-20.50
Total Expenditure (Excl Depreciation)
1,761.78
0
1,761.78
Operating Profit (PBDIT) excl Other Income
288.03
0.00
288.03
Other Income
87.18
0
87.18
Operating Profit (PBDIT)
521.53
0
521.53
Interest
1.56
0
1.56
Exceptional Items
-249.60
0
-249.60
Gross Profit (PBDT)
936.88
0
936.88
Depreciation
164.69
0
164.69
Profit Before Tax
105.68
0
105.68
Tax
-8.76
0
-8.76
Provisions and contingencies
0
0
0.00
Profit After Tax
112.70
0
112.70
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
112.70
0
112.70
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.06
0
-0.06
Other related items
0.00
0.00
0.00
Consolidated Net Profit
112.64
0
112.64
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
7,437.65
0
7,437.65
Earnings per share (EPS)
0.22
0
0.22
Diluted Earnings per share
0.22
0
0.22
Operating Profit Margin (Excl OI)
13.16%
0%
0.00
13.16%
Gross Profit Margin
13.19%
0%
0.00
13.19%
PAT Margin
5.50%
0%
0.00
5.50%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 204.98 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 18.63% vs -34.60% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 11.26 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -71.60% vs 59.81% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 43.44 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -19.45% vs -16.01% in Dec 2024
Annual - Interest
Interest 0.16 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 45.45% vs 37.50% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.16%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






